Skip to content
Dr. Doanh Nguyen portrait

Doanh Nguyen, MD FAAAAI

Senior Scientific Collaborator, Institute for Allergic Inflammation

Allergist Immunologist | Texas Allergy Group

Dr. Doanh Nguyen is board-certified allergist and immunologist and Diplomate of the American Board of Allergy & Immunology, the American Board of Internal Medicine, and the National Board of Physicians and Surgeons.

Dr. Nguyen earned his bachelor's degree in Biochemistry and Biophysics from the University of Houston and his medical degree from the University of Texas Medical School at Houston. He completed his internal medicine residency at University Hospitals, Case Western Reserve University, followed by fellowship training in Allergy and Immunology at Children's Hospital in Los Angeles and the University of South Florida. His fellowship research focused on subcutaneous immunoglobulin therapy for primary humoral immunodeficiency and atopic dermatitis, and he helped establish a standardized Atopic Dermatitis Clinic during his training. He has served as a Clinical Professor in the Department of Family and Community Medicine at Baylor College of Medicine since 2015.

Dr. Nguyen's current research, conducted through the Texas Allergy Group Clinical Research Unit and the Institute for Allergic Inflammation, focuses on systemic allergic inflammation, inflammatory biomarkers, and clinical mechanisms of tolerance breaking. His investigations examine connections between chronic airway inflammation and remote epithelial dysfunction, proteinuria, thyroiditis, viral activation, and early autoimmunity. He is committed to developing biomarker-guided therapeutic interventions that detect and mitigate systemic inflammation before organ-level complications occur.

Dr. Nguyen also has extensive expertise in mast cell diseases, including Mast Cell Activation Syndrome (MCAS), chronic urticaria, angioedema, and complex mast-cell-driven inflammatory disorders. He provides comprehensive diagnostic evaluation and individualized treatment plans for patients with mast cell-related symptoms ranging from multisystem reactivity to chronic inflammatory manifestations.

Dr. Nguyen cares for children and adults with asthma, allergic rhinitis, chronic sinusitis, chronic cough, hives, eczema, food allergies, drug and insect allergies, primary immunodeficiency, MCAS, and conditions driven by systemic allergic inflammation. He is particularly dedicated to improving quality of life for patients with severe eczema, asthma, chronic hives, mast cell disorders, and immune dysregulation.

PUBLICATIONS/PRESENTATIONS

  • Nguyen D, Deitiker P. Sustained control of recalcitrant chronic spontaneous urticaria after initiation of inflammatory airway diseases treatment: two case reports. J Med Case Rep 2024 Feb 23;18(1):113. PubMed ID 10893739

  • Hoang J, Nguyen D. Severe, Unexplained Abdominal Pain Associated with Untreated Asthma. ACAAI Annual Meeting 2021, New Orleans, LA

  • Niebur HB, Duff CM, Shear GF, Nguyen D, Alberdi TK, Dorsey MJ, Sleasman JW. Efficacy and tolerability of 16% subcutaneous immunoglobulin compared with 20% subcutaneous immunoglobulin in primary antibody deficiency. Clinical & Experimental Immunology. 2015. March 11

  • Elizalde A, Perez EE, Sriaroon P, Nguyen D, Lockey RF, Dorsey MJ. Intensive educational course in allergy and immunology. Allergy 2012. Sep 67(9):1085-6

  • Poster/Abstract. Subcutaneous Hizentra® (20%) is better tolerated and shares similar efficacy compared to Subcutaneous Vivaglobin® (16%). AAAAI Annual Meeting 2012 Orlando, FL

  • Poster/Abstract. Subcutaneous Vivaglobin® Replacement Therapy in Patients with Humoral Immunodeficiency Confers Protective Antibody Titers to Major Organisms, ACAAI Annual Meeting 2011, Boston, MA; Oral presentation at the World Allergy Congress (WAC) Annual Meeting 2011, Cancun, Mexico

  • Poster/Abstract. Elevation of Soluble CD14 Levels Support Chronic Innate Immune Activation in Subjects with CVID and SLE Compared to Healthy Subjects, AAAAI Annual Meeting 2011, San Francisco, CA and USF Research Day 2010, Tampa, FL

  • Poster/Abstract. Quality of Life Is Maintained in Common Variable Immunodeficiency During Long-term Immunoglobulin Replacement Therapy, AAAAI Annual Meeting 2010, New Orleans, LA and CWRU Research Day 2010, Cleveland, OH